MediTech Chronicles

If you are a pharmacy student or a researcher in 2026, the old textbooks aren't telling you the whole story. For decades, we learned that solubility was simple: "Like dissolves like." We memorized the Noyes-Whitney equation, looked at a solubility chart , and mixed powders in a beaker. But today, that approach is obsolete. With 90% of new drug candidates classified as "poorly soluble" (BCS Class II and IV), the industry faces an "insolubility crisis." The modern lab doesn't just "dissolve" drugs; it engineers them. We use Artificial Intelligence to predict solubility limits before a molecule is even synthesized. We use lasers and supercomputers to force "brick dust" molecules into the bloodstream. This article is your guide to the New Science of Solubility . We will decode the modern math, the AI tools like FastSolv , and the breakthrough technologies like Lipid Nanoparticles (LNPs) that are redefining drug delivery in ...

The Science Behind Solubility: Solubility Formula, Solubility Chart, and Drug Delivery system In the intricate world of pharmaceuticals, understanding solubility is crucial for effective drug development and delivery. Solubility, the ability of a substance to dissolve in a solvent, plays a pivotal role in determining a drug's bioavailability, efficacy, and even its safety profile.  In this article, we will delve into the science behind solubility, exploring solubility formulas, solubility charts, and their significance in drug delivery. The Basics of Solubility: Solubility forms the foundation of drug formulation. It is governed by various factors, including the drug's molecular structure, the solvent's properties, and temperature. When a drug's solubility is low, its absorption into the bloodstream can be compromised, resulting in suboptimal therapeutic effects. To overcome this, scientists employ solubility-enhancing techniques, making solubility formulas and charts i...

Researchers target ocular drug delivery market Researchers have developed a drug delivery device which attaches to the eye and could negate the need for repeat injections. The team from the University of Southern California has created a simple polymer device which is inserted under the conjunctiva and delivers a therapeutic to the affected area. In time the device could come to replace the intravitreal injections which patients suffering from glaucoma and related eye diseases currently have to be administered with.  Ellis Meng, researcher on the project, was keen to emphasise further refinements are in the pipeline. She said: " This prototype isn't optimally sized; it's our first go at proving the concept. We're now building a next-generation device ."  The one centimetre long prototype consists of a refillable reservoir sutured to the sclera which contains the therapeutic. Leading off this is a flexible tube which is inserted into the side of the eye and throug...